Biomodal

Biomodal (formerly Cambridge Epigenetix) is a Cambridge, UK genomics and epigenetics company whose duet multiomics solutions capture genetic and epigenetic information from a single low-input DNA sample in one experiment, giving researchers access to the six-base genome (the four canonical bases plus 5-methylcytosine and 5-hydroxymethylcytosine). Its products include the duet multiomics solution evoC and duet +modC library-prep assays, the biomodal CLI and duet post-sequencing pipeline (alignment, methylation quantification, and variant calling), and the modality XPLR analysis software. The technology is applied to cancer and liquid-biopsy research, neurodegenerative disease, aging, precision medicine, and non-invasive prenatal testing. Biomodal is a portfolio company of GV (Google Ventures) and was added to the API Evangelist network as a life-sciences provider profile.

Biomodal is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Genomics, Epigenetics, and Multiomics.

Biomodal’s developer surface includes documentation, engineering blog, support, CLI, and 6 more developer resources.

🌐 Visit website 📡 Source on GitHub

17.0/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0

0 APIs

CompanyLife SciencesGenomicsEpigeneticsMultiomicsDNA SequencingBioinformaticsPrecision Medicine

Kin Score

Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0

Composite quality — 17.0/100 · emerging

Contract Quality 0.0 / 21

Developer Ergonomics 5.7 / 17

Access Clarity 4.7 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 2.6 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/biomodal: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Get Started 2

Portal, sign-up, and the first successful call

DeveloperPortal

DeveloperPortal

Login

Documentation 1

Reference material describing how the API behaves

Documentation

Documentation

Build 1

SDKs, sample code, and the tooling you integrate with

CLI

CLI

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: biomodal
name: Biomodal
description: Biomodal (formerly Cambridge Epigenetix) is a Cambridge, UK genomics and epigenetics company whose duet multiomics
  solutions capture genetic and epigenetic information from a single low-input DNA sample in one experiment, giving researchers
  access to the six-base genome (the four canonical bases plus 5-methylcytosine and 5-hydroxymethylcytosine). Its products
  include the duet multiomics solution evoC and duet +modC library-prep assays, the biomodal CLI and duet post-sequencing
  pipeline (alignment, methylation quantification, and variant calling), and the modality XPLR analysis software. The technology
  is applied to cancer and liquid-biopsy research, neurodegenerative disease, aging, precision medicine, and non-invasive
  prenatal testing. Biomodal is a portfolio company of GV (Google Ventures) and was added to the API Evangelist network as
  a life-sciences provider profile.
url: https://raw.githubusercontent.com/api-evangelist/biomodal/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://biomodal.com/wp-content/uploads/2023/05/biomodal-social-share.webp
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Life Sciences
- Genomics
- Epigenetics
- Multiomics
- DNA Sequencing
- Bioinformatics
- Precision Medicine
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://biomodal.com
- type: DeveloperPortal
  url: https://software-docs.biomodal.com/en/latest/index.html
- type: Documentation
  url: https://biomodal.com/documentation/
- type: Blog
  url: https://biomodal.com/news/
- type: Support
  url: https://biomodal.com/contact/
- type: Login
  url: https://app.biomodal.com
- type: TermsOfService
  url: https://biomodal.com/terms-of-use/
- type: PrivacyPolicy
  url: https://biomodal.com/privacy-policy/
- type: CLI
  url: cli/biomodal-cli.yml
- type: DomainSecurity
  url: security/biomodal-domain-security.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence